Labiotech.eu

News and Trends 31 Oct 2018

Forget Daily Pills: HIV Could Be Treated With Monthly Injections

A monthly antiviral injection may be as good as daily HIV drugs for suppressing infections, reports the British biotech ViiV Healthcare. This could make the treatment of HIV easier for patients and improve compliance. In the first five months of a Phase IIb trial, the company gave 274 HIV-infected adults three daily oral antiretrovirals. After […]

October 31, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 31 Oct 2018

Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results

An antibody therapy for the blood cancer multiple myeloma achieved positive results at Phase III, decreasing the risk of the disease getting worse and patient death by 45% in a Phase III trial. The blockbuster antibody daratumumab, developed by Janssen using a license from the Danish company Genmab, was given to patients in combination with […]

October 31, 2018 - 2 minutesmins - By Jonathan Smith

Interview 31 Oct 2018

Biotech Investment Strategies: How, When and Where to Invest

How, when and where to invest in a biotech company can be essential to the success of both specialized investors and the companies receiving the money. At Refresh Basel, I spoke to Chandra Leo, Partner at the life sciences VC firm HBM Partners, to discuss investment strategies in biotech and his advice for companies seeking […]

October 31, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

More News! 30 Oct 2018

British Diagnostics Firm Develops More Accurate Fetal Health Screen

A lab kit from British diagnostics company Angle could make non-invasive fetal health screens more accurate by analyzing whole fetal cells in the mother’s blood. To screen your unborn baby for genetic conditions, the most accurate current option is invasive techniques such as amniocentesis. These techniques take samples directly from the womb that contain fetal […]

October 30, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 30 Oct 2018

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

What do shuttles, bubbles and ultrasound have in common? They are all methods that can all be used to target the blood–brain barrier and make treating brain diseases such as cancer and Alzheimer’s easier. The blood–brain barrier is the gatekeeper to the brain. This highly selective protective sheath regulates the flow of substances in and […]

October 30, 2018 - 7 minutesmins - By External Contributor

News and Trends 29 Oct 2018

Tree Bark Could be a Sustainable Source of Adhesives and Sugars

Researchers at the Technical Research Centre of Finland are making it easier to process spare tree bark into useful resins and sugars. In Finland, three million tonnes of bark is produced from softwood trees such as firs and pines, and, despite its potential as a source of industrial products, a lot is thrown away. “Bark […]

October 29, 2018 - 2 minutesmins - By Jonathan Smith

More News! 29 Oct 2018

Plasma Replacement Therapy Promising in Alzheimer’s Patients

A blood plasma replacement therapy from Spanish company Grifols reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo. The researchers monitored the cognitive symptoms of 496 patients with Alzheimer’s disease in the Phase IIb/III trial. Over 14 months, the therapy had no effect in patients with mild Alzheimer’s, but the […]

October 29, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 27 Oct 2018

How Will Biotech Influence the Technology of the Future?

Dutch designer Nicole Spit looks into the future of consumer biotech products with a series of speculative design objects being exhibited at the Dutch Design Week. Biotechnology is already revolutionizing healthcare. Soon, it might also take over our daily lives, but are we ready for it? Designer Nicole Spit wants to make us think about […]

October 27, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Oct 2018

BASF Will Use CRISPR to Gene-Edit Crops and Microbes

The German chemical giant BASF has obtained a non-exclusive license from the US Broad Institute for the use of CRISPR-Cpf1 gene-editing technology in agricultural and microbiological applications. CRISPR-Cas9 is a fast and easy technique for editing the genome that has gained worldwide fame. It has the potential for use in many applications such as in […]

October 26, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 26 Oct 2018

Danish Biotech Closes €79M Series C to Develop Inhaled Lung Disease Drug

The Danish company Galecto Biotech can breathe a contented sigh. Its Series C funding round has raised €79M to finance a Phase II/III trial of its inhaled drug for a deadly lung disease. The amount raised is 30% higher than the company’s initial €60M goal, Galecto’s CEO, Hans Schambye, told me. “Being able to raise […]

October 26, 2018 - 2 minutesmins - By Jonathan Smith

Startup Scout 26 Oct 2018

This Biotech Develops Biodegradable Antimicrobial Paint For Your Yacht

It is time to sail to Portugal for our Lisbon-based biotech of the week, BioMimetx. The company is developing biodegradable antimicrobial paint additives to help marine industries keep their surfaces clean of microbe buildup. Mission: Are you an environmentally conscious yacht owner who wants a clean boat bottom? If so, you are in luck, as […]

October 26, 2018 - 4 minutesmins - By Jonathan Smith

News and Trends 25 Oct 2018

Invisible Eye Glucose Monitor Accurately Measures Sugar Levels

In a small trial in the Netherlands, Dutch firm NovioSense has shown that its device for measuring blood sugar levels through tear fluid is comparable to current continuous glucose sensors. Currently, the standard method for people with diabetes to measure their blood sugar requires finger pricking multiple times per day, which can be painful and […]

October 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us